Table I.
Characteristics of subjects with Parkinsons Disease (PD), multiple system atrophy (MSA) or dementia with Lewy Bodies (DLB). Values are expressed as mean +/- standard deviation where applicable. P –values are shown for those characteristics by which subjects were matched.
| PD | MSA | DLB | P-value | |
|---|---|---|---|---|
| N | 14 | 12 | 14 | |
| Sex (F/M) | 4/10 | 5/7 | 4/10 | 0.12 |
| Age (years) | 65 ± 6.7 | 66.9 ± 11.3 | 70 ± 7.5 | 0.34 |
| Education (years) | 17.9 ± 2.8 | 15.9 ±2.8 | 16.6 ± 2.8 | 0.34 |
| Disease duration (years) | 4.1 ± 3.5 | 5.4 ± 3.6 | 5.7 ± 3.5 | 0.54 |
| Handedness (R/L) | 11/2 | 12/0 | 14/0 | |
| Dopaminergic agent total (n) | 10 | 2 | 9 | |
| L-DOPA | 9 | 2 | 8 | |
| Dopamine Receptor agonist | 8 | 1 | 1 | |
| Amantadine | 1 | 0 | 1 | |
| Cholinesterase inhibitor (n) | 1 | 1 | 9 | |
| Anti-depressant (n) | 5 | 5 | 5 | |
| Anti-psychotic (n) | 0 | 1 | 3 | |
| Anti-cholinergic agent | 2 | 0 | 0 |